Dapagliflozin add-on to metformin in type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled 102-week trial

Clifford J. Bailey, Jorge L. Gross, Delphine Hennicken, Nayyar Iqbal, Traci A. Mansfield, James F. List

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Dapagliflozin add-on to metformin in type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled 102-week trial'. Together they form a unique fingerprint.

Medicine & Life Sciences